uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals
Iceland Heart Assoc, Res Inst, Kopavogur, Iceland.;Landspitali Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland..
Iceland Heart Assoc, Res Inst, Kopavogur, Iceland.;Univ Iceland, Fac Med, Reykjavik, Iceland..
Iceland Heart Assoc, Res Inst, Kopavogur, Iceland..
Iceland Heart Assoc, Res Inst, Kopavogur, Iceland..
Show others and affiliations
2016 (English)In: Clinical Chemistry, ISSN 0009-9147, E-ISSN 1530-8561, Vol. 62, no 4, 623-630 p.Article in journal (Refereed) PublishedText
Abstract [en]

BACKGROUND: The objective of this study was to investigate the predictive power of a high-sensitivity cardiac troponin I (hs-cTnI) assay for cardiovascular events and mortality in a large population of older community dwellers.

METHODS: Blood was collected from 5764 individuals (age 66-98 years) during the period of 2002-2006 and the outcome as to all-cause death and incidence of cardiovascular disease (CVD) and coronary heart disease (CHD) followed up to 10 years. hs-cTnI (Abbott) was measured in serum to assess the association of this marker with CVD, CHD and death, and finally, to compare the results with conventional risk factors by multivariable statistical analysis.

RESULTS: The median (interquartile range) concentrations of hs-cTnI were 8.4 ng/L (5.6-14.2 ng/L) and 5.3 ng/L (3.8-8.1 ng/L) in men (2416) and women (3275), respectively, and the concentrations increased linearly with age. Outcomes as to all-cause death and incidence of CVD and CHD were significantly associated with increasing concentrations of hs-cTnI beginning well below the 99th percentile concentrations. The associations with outcome remained after adjustments for conventional risk factors and were similar in men and women.

CONCLUSIONS: Our findings suggest that hs-cTnI reflects the status of the myocardium even in seemingly healthy individuals and that the measurements of hs-cTnI may be useful for primary prediction of heart disease; this should form the basis for future prospective clinical trials for determining whether measuring hs-cTnI can be used in the prevention of CVD/CHD.

Place, publisher, year, edition, pages
2016. Vol. 62, no 4, 623-630 p.
National Category
Cardiac and Cardiovascular Systems
URN: urn:nbn:se:uu:diva-293009DOI: 10.1373/clinchem.2015.250811ISI: 000373097100013PubMedID: 26936931OAI: oai:DiVA.org:uu-293009DiVA: diva2:927469
Available from: 2016-05-12 Created: 2016-05-11 Last updated: 2016-05-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Venge, Per
By organisation
Biochemial structure and function
In the same journal
Clinical Chemistry
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 57 hits
ReferencesLink to record
Permanent link

Direct link